Norway
· Delayed Price · Currency is NOK IDEX Biometrics ASA Statistics
Total Valuation
IDEX Biometrics ASA has a market cap or net worth of NOK 206.64 million. The enterprise value is 245.81 million.
| Market Cap | 206.64M |
| Enterprise Value | 245.81M |
Important Dates
The next estimated earnings date is Thursday, November 14, 2024.
| Earnings Date | Nov 14, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
IDEX Biometrics ASA has 338.75 million shares outstanding. The number of shares has increased by 23.52% in one year.
| Shares Outstanding | 338.75M |
| Shares Change (YoY) | +23.52% |
| Shares Change (QoQ) | +2.22% |
| Owned by Insiders (%) | 41.85% |
| Owned by Institutions (%) | 13.06% |
| Float | 187.88M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 7.22 |
| PB Ratio | 7.19 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.95 |
| EV / Sales | 10.52 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -1.01 |
Financial Position
The company has a current ratio of 1.05, with a Debt / Equity ratio of 229.78.
| Current Ratio | 1.05 |
| Quick Ratio | 0.37 |
| Debt / Equity | 229.78 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.25 |
| Interest Coverage | -19.60 |
Financial Efficiency
Return on equity (ROE) is -217.51% and return on invested capital (ROIC) is -100.10%.
| Return on Equity (ROE) | -217.51% |
| Return on Assets (ROA) | -71.99% |
| Return on Capital (ROIC) | -100.10% |
| Revenue Per Employee | 543,230 |
| Profits Per Employee | -6.01M |
| Employee Count | 43 |
| Asset Turnover | 0.11 |
| Inventory Turnover | 0.36 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -80.63% in the last 52 weeks. The beta is 2.34, so IDEX Biometrics ASA's price volatility has been higher than the market average.
| Beta (5Y) | 2.34 |
| 52-Week Price Change | -80.63% |
| 50-Day Moving Average | 1.27 |
| 200-Day Moving Average | 1.85 |
| Relative Strength Index (RSI) | 26.42 |
| Average Volume (20 Days) | 4,174,570 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, IDEX Biometrics ASA had revenue of NOK 23.36 million and -258.40 million in losses. Loss per share was -0.94.
| Revenue | 23.36M |
| Gross Profit | -1.35M |
| Operating Income | -255.81M |
| Pretax Income | -256.03M |
| Net Income | -258.40M |
| EBITDA | -244.75M |
| EBIT | -255.81M |
| Loss Per Share | -0.94 |
Balance Sheet
The company has 21.92 million in cash and 61.09 million in debt, giving a net cash position of -39.17 million or -0.12 per share.
| Cash & Cash Equivalents | 21.92M |
| Total Debt | 61.09M |
| Net Cash | -39.17M |
| Net Cash Per Share | -0.12 |
| Equity (Book Value) | 26.59M |
| Book Value Per Share | 0.08 |
| Working Capital | 5.56M |
Cash Flow
In the last 12 months, operating cash flow was -243.04 million and capital expenditures -745,950, giving a free cash flow of -243.79 million.
| Operating Cash Flow | -243.04M |
| Capital Expenditures | -745,950 |
| Free Cash Flow | -243.79M |
| FCF Per Share | -0.72 |
Margins
| Gross Margin | -5.79% |
| Operating Margin | -1,095.12% |
| Pretax Margin | -1,096.08% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | -1,043.66% |
Dividends & Yields
IDEX Biometrics ASA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -23.52% |
| Shareholder Yield | -23.52% |
| Earnings Yield | -153.29% |
| FCF Yield | -117.98% |
Stock Splits
The last stock split was on January 9, 2024. It was a reverse split with a ratio of 0.2.
| Last Split Date | Jan 9, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.2 |